期刊文献+

hnRNP K siRNA真核表达载体的构建及其在A549肺癌细胞中沉默效应的研究

Construction of eukaryotic expression vector of siRNA specific for hnRNP K and characterization of its efficiency in A549 lung carcinoma cell line
下载PDF
导出
摘要 目的构建hnRNP K特异性siRNA真核表达载体,体外观察对hnRNP K基因的沉默作用。方法采用基因克隆技术,将合成的特异性hnRNP K RNA干扰寡核苷酸序列插入真核表达载体pSUPER,构建hnRNP K siRNA真核表达载体。采用Lipofect AMINE2000将pSUPER空载体和3个重组质粒(pSUPER/hnRNP K siRNAa,pSUPER/hnRNP K siRNAc和pSUPER/siRNAn)分别导入A549肺癌细胞(a、c、n分别代表hnRNP K编码序列中的A链和C链,以及无意义的对照序列Non链)。24 h后用RT-PCR和Western blot技术检测各实验组肺癌细胞内hnRNP K mRNA及蛋白水平的表达情况。结果成功构建了hnRNP K siRNA真核表达载体。转染hnRNP K siRNAa、hnRNP K siRNAc的肺癌细胞24 h后hnRNP K mRNA相对表达量分别为0.24±0.53和0.28±0.57,较对照组显著降低(P均<0.01);hnRNP K蛋白灰度值分别为0.23±0.11和0.28±0.09,较对照组显著降低(P均<0.05)。结论构建的RNA干扰真核表达载体能明显干扰A549细胞hnRNP K mRNA及蛋白的表达,为进一步研究hnRNP K基因的功能并应用于肺癌的治疗研究奠定了基础。 Objective To construct small interfering RNA (siRNA) eukaryotic expression vector specific for human hnRNP K gene, and to observe its silencing effects on hnRNP K gene in A549 cells. Methods The expression vectors of pSUPER/hnRNP K siRNAa, pSUPER/hnRNP K siRNAc and pSUPER/siRNAn were constructed by gene recombination and then transfected into the A549 lung carcinoma cell line by using Lipofect AMINE2000 (a and c respectively represented A and C fragments in hnRNP K coding sequence contained 19 nts, n represented nonsense fragment as control). The mRNA and protein were harvested after 24 h and analyzed for the expression of hnRNP K by RT-PCR and Western blot respectively. Results The siRNA vector targeted to hnRNP K successfully decreased hnRNP K mRNA and protein levels 24 h after transfection in A549 cells. Relative expressed doses of hnRNP K mRNA in lung cancer ceils transfected by hnRNP K siRNAa and hnRNP K siRNAc respectively were 0. 24 ± 0. 53 and 0. 28 ± 0. 57 after 24 h, which were significantly lower than those in the control group (both P 〈 0. 01 ). The gray scale values of hnRNP K protein were 0. 23 ± 0. 11 and 0. 28 ± 0. 09 respectively, which were also significantly lower than those in the control group ( both P 〈 0. 05 ). And pSUPER/hnRNP K siRNAa was the most effective one. Conclusion Eukaryotic expression vector of siRNA specific for hnRNP K is successfully constructed,which lays the basis for the function study of hnRNP K gene and its application in the treatment of lung carcinoma.
出处 《中国呼吸与危重监护杂志》 CAS 2008年第5期350-353,362,共5页 Chinese Journal of Respiratory and Critical Care Medicine
基金 教育部博士点基金(编号:20050610056)
关键词 不均一核糖核蛋白K 小干扰RNA 真核表达载体 Heterogeneous nuclear ribonucleoprotein K Small interfering RNA Eukaryotic expression vector
  • 相关文献

参考文献1

二级参考文献60

  • 1[1]Fire A, Xu S, Montgomery MK, et al. Potent and specific genetics interference by double-stranded RNA in Caenorhabitis elegans. Nature 1998; 391:806-11.
  • 2[2]Jorgensen R. Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol 1990; 8:340-4.
  • 3[3]Romano N, Macino G. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol 1992; 6: 3343-53.
  • 4[4]Dave RS, Pomerantz RJ. RNA interference: on the to an to alternate therapeutic strategy. Rev Med Virol 2003; 13: 373-85.
  • 5[5]Plasterk RA. RNA silencing: the genome's immune system.Science, 2002; 296: 1263-5.
  • 6[6]Yin JQ, Wan Y. siRNA-mediated gene regulation system. Int J Mol Med 2002; 10:355-65.
  • 7[7]Yin JQ, Cao JS, Shao RG, et al. SiRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Onc 2003; 3:1-11.
  • 8[8]Liu TG, Yin JQ, Shang BY, et al. Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer. Cancer Gene Therapy (In Press).
  • 9[9]Gitlin L, Myers CP, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002; 418:430-4.
  • 10[10]Saleh MC, VanRij RP, Andino R. RNA silencing in viral infections:insights from poliovirus. Virus Res 2004; 102:11-7.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部